<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(6)</volume><submitter>Le Thiec M</submitter><pubmed_abstract>Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters using different segmentation methods in patients with localized anal squamous cell carcinoma (SCC). Eighty-one patients with FDG-PET before radiochemotherapy were retrospectively analyzed. Semiquantitative data were measured with three fixed thresholds (35%, 41% and 50% of Maximum Standardized Uptake Value (SUVmax)) and four segmentation methods based on iterative approaches (Black, Adaptive, Nestle and Fitting). Metabolic volumes of primary anal tumour (P-MTV) and total tumour load (T-MTV: P-MTV+ lymph node MTV) were calculated. The primary endpoint was event-free s</pubmed_abstract><journal>Cancers</journal><pagination>E1512</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7352672</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.</pubmed_title><pmcid>PMC7352672</pmcid><pubmed_authors>Maucherat B</pubmed_authors><pubmed_authors>Rousseau C</pubmed_authors><pubmed_authors>Hamidou H</pubmed_authors><pubmed_authors>Rio E</pubmed_authors><pubmed_authors>Guillerminet C</pubmed_authors><pubmed_authors>Meyer VG</pubmed_authors><pubmed_authors>Campion L</pubmed_authors><pubmed_authors>Hiret S</pubmed_authors><pubmed_authors>Le Thiec M</pubmed_authors><pubmed_authors>Testard A</pubmed_authors><pubmed_authors>Morel O</pubmed_authors><pubmed_authors>Girault S</pubmed_authors><pubmed_authors>Rusu D</pubmed_authors><pubmed_authors>Ferrer L</pubmed_authors><pubmed_authors>Kraeber-Bodere F</pubmed_authors><pubmed_authors>Lacombe M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.</name><description>Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters using different segmentation methods in patients with localized anal squamous cell carcinoma (SCC). Eighty-one patients with FDG-PET before radiochemotherapy were retrospectively analyzed. Semiquantitative data were measured with three fixed thresholds (35%, 41% and 50% of Maximum Standardized Uptake Value (SUVmax)) and four segmentation methods based on iterative approaches (Black, Adaptive, Nestle and Fitting). Metabolic volumes of primary anal tumour (P-MTV) and total tumour load (T-MTV: P-MTV+ lymph node MTV) were calculated. The primary endpoint was event-free s</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-26T08:12:06.191Z</modification><creation>2025-04-06T12:38:49.175Z</creation></dates><accession>S-EPMC7352672</accession><cross_references><pubmed>32527039</pubmed><doi>10.3390/cancers12061512</doi></cross_references></HashMap>